disease of the heart muscle ischemische cardiomyopathy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: *Patient with ischemic cardiomyopathy with an indication for de novo ICD implantation for primary prevention, according to ESC guidelines or local standards (MADIT II population) *Written informed consent / willingness and ability to comply with the protocol
Exclusion criteria
Exclusion criteria: *Contraindication for MRI *Severe renal dysfunction (if leading to a contraindication for the admission of Gadolinium with MRI) *Indication for secondary prevention ICD implantation *Class I indication for CRT-D *Heart failure with New York Heart Association functional class IV *LV ejection fraction >40% *Age 85 years *Women that are pregnant, lactating or planning to become pregnant *Participating in any other clinical trial with active intervention(s) during the course of this clinical investigation *Life expectancy less than 1 year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| * % Relative infarct transmurity measured by LGE-CMR (Late Gadolinium Enhanced Cardiac Magnetic Resonance ) *Appropriate ICD intervention (shock and/or ATP) The primary alternative hypothesis states that the mean relative infarct transmurality (RIT) is different in patients with (RITshock or ATP ) and without appropriate ICD intervention, i.e. shock or ATP. · Null hypothesis H0: RITshock or ATP = RITno shock or ATP · Alternative hypothesis HA: RITshock or ATP¹ RITno shock or AT | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that appropriate ICD Intervention can be predicted by RIT and other baseline risk markers determined before ICD implantation. Because of a lack of clinical data, hypotheses cannot be pre-specified in a confirmatory setting. Thus, the data will be analyzed in an exploratory setting to generate hypotheses for a future confirmatory clinical investigation | — |
Countries
Netherlands